<DOC>
	<DOC>NCT01809587</DOC>
	<brief_summary>The purpose of the study is to evaluate the safety and efficacy of IQP-PO-101 in regulating the bowel movement frequency</brief_summary>
	<brief_title>IQP-PO-101 for the Regulation of Bowel Movement Frequency</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>A subject must have experienced 2 4 bowel movements per week and at least 2 of the following symptoms over the preceding 3 months (selfreported): Excessive straining Lumpy or hard stools Sensation of anorectal obstruction A sense of incomplete evacuation of bowel movements A need for digital manipulation to facilitate evacuation Recorded between 4 and 9 defecations in the 14day bowel movement diary during the runin period Subjects of childbearing potential must agree to use appropriate contraceptive methods during runin and treatment period Commitment to avoid the use of any laxatives and/ or other medicinal products/ supplements that may interfere with bowel movement frequency during the runin and treatment period Written informed consent. Known sensitivity to the ingredients of the device Any organic gastrointestinal diseases, congenital or otherwise Presence of occult blood on screening Constipation that may have been druginduced Use of any laxative/ products that help ease bowel movements within 7 days of the screening visit Constipation other than idiopathic constipation Presence of other factor(s) that, in the investigator's judgement, should preclude subject participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>